COMBINED HORMONOTHERAPY WITH GNRG ANALOGUE AND INTRAUTERINE LEVONORGESTREL-RELEASING SYSTEM OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA: PROSPECTIV PILOT RESEARCH

The article presents the results of organ-preserving treatment protocol of atypical endometrial hyperplasia and well-differentiated endometrial carcinoma in young women. This protocol was applied in 24 patients. The period of patients observation was 3—6 years. During 6—9 months the patients were gi...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	A. I. Pashov, V. B. Tskhai, E. N. Sivova
Format:	article
Langue:	RU
Publié:	Scientific Сentre for Family Health and Human Reproduction Problems 2012
Sujets:	atypical endometrial hyperplasia gnrg analogue levonorgestrel intrauterine device lng-iud) well-differentiated endometrial carcinoma Science Q
Accès en ligne:	https://doaj.org/article/d9b93518e4ee49988ee1d5e0c55e2ba9
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

id	oai:doaj.org-article:d9b93518e4ee49988ee1d5e0c55e2ba9
record_format	dspace
spelling	oai:doaj.org-article:d9b93518e4ee49988ee1d5e0c55e2ba92021-11-23T06:14:19ZCOMBINED HORMONOTHERAPY WITH GNRG ANALOGUE AND INTRAUTERINE LEVONORGESTREL-RELEASING SYSTEM OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA: PROSPECTIV PILOT RESEARCH2541-94202587-9596https://doaj.org/article/d9b93518e4ee49988ee1d5e0c55e2ba92012-05-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/852https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596The article presents the results of organ-preserving treatment protocol of atypical endometrial hyperplasia and well-differentiated endometrial carcinoma in young women. This protocol was applied in 24 patients. The period of patients observation was 3—6 years. During 6—9 months the patients were given GnRG analogue with add-back therapy. Intrauterine levonorgestrel-releasing system was inserted with therapeutic purpose for the period of not less than 6 months in atypical endometrial hyperplasia and for 1 year for well differentiated endometrial carcinoma. Combined using of GnRG analogue and intrauterine levonorgestrel-releasing system is effective method for treatment of atypicalendometrial hyperplasia and endometrial carcinoma stage I А in young women, especially in cases of unrealized fertility and can be considered as an alternative way to hysterectomy.A. I. PashovV. B. TskhaiE. N. SivovaScientific Сentre for Family Health and Human Reproduction Problemsarticleatypical endometrial hyperplasiagnrg analoguelevonorgestrel intrauterine device lng-iud)well-differentiated endometrial carcinomaScienceQRUActa Biomedica Scientifica, Vol 0, Iss 3(1), Pp 43-45 (2012)
institution	DOAJ
collection	DOAJ
language	RU
topic	atypical endometrial hyperplasia gnrg analogue levonorgestrel intrauterine device lng-iud) well-differentiated endometrial carcinoma Science Q
spellingShingle	atypical endometrial hyperplasia gnrg analogue levonorgestrel intrauterine device lng-iud) well-differentiated endometrial carcinoma Science Q A. I. Pashov V. B. Tskhai E. N. Sivova COMBINED HORMONOTHERAPY WITH GNRG ANALOGUE AND INTRAUTERINE LEVONORGESTREL-RELEASING SYSTEM OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA: PROSPECTIV PILOT RESEARCH
description	The article presents the results of organ-preserving treatment protocol of atypical endometrial hyperplasia and well-differentiated endometrial carcinoma in young women. This protocol was applied in 24 patients. The period of patients observation was 3—6 years. During 6—9 months the patients were given GnRG analogue with add-back therapy. Intrauterine levonorgestrel-releasing system was inserted with therapeutic purpose for the period of not less than 6 months in atypical endometrial hyperplasia and for 1 year for well differentiated endometrial carcinoma. Combined using of GnRG analogue and intrauterine levonorgestrel-releasing system is effective method for treatment of atypicalendometrial hyperplasia and endometrial carcinoma stage I А in young women, especially in cases of unrealized fertility and can be considered as an alternative way to hysterectomy.
format	article
author	A. I. Pashov V. B. Tskhai E. N. Sivova
author_facet	A. I. Pashov V. B. Tskhai E. N. Sivova
author_sort	A. I. Pashov
title	COMBINED HORMONOTHERAPY WITH GNRG ANALOGUE AND INTRAUTERINE LEVONORGESTREL-RELEASING SYSTEM OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA: PROSPECTIV PILOT RESEARCH
title_short	COMBINED HORMONOTHERAPY WITH GNRG ANALOGUE AND INTRAUTERINE LEVONORGESTREL-RELEASING SYSTEM OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA: PROSPECTIV PILOT RESEARCH
title_full	COMBINED HORMONOTHERAPY WITH GNRG ANALOGUE AND INTRAUTERINE LEVONORGESTREL-RELEASING SYSTEM OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA: PROSPECTIV PILOT RESEARCH
title_fullStr	COMBINED HORMONOTHERAPY WITH GNRG ANALOGUE AND INTRAUTERINE LEVONORGESTREL-RELEASING SYSTEM OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA: PROSPECTIV PILOT RESEARCH
title_full_unstemmed	COMBINED HORMONOTHERAPY WITH GNRG ANALOGUE AND INTRAUTERINE LEVONORGESTREL-RELEASING SYSTEM OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA: PROSPECTIV PILOT RESEARCH
title_sort	combined hormonotherapy with gnrg analogue and intrauterine levonorgestrel-releasing system of atypical endometrial hyperplasia and well-differentiated endometrial carcinoma: prospectiv pilot research
publisher	Scientific Сentre for Family Health and Human Reproduction Problems
publishDate	2012
url	https://doaj.org/article/d9b93518e4ee49988ee1d5e0c55e2ba9
work_keys_str_mv	AT aipashov combinedhormonotherapywithgnrganalogueandintrauterinelevonorgestrelreleasingsystemofatypicalendometrialhyperplasiaandwelldifferentiatedendometrialcarcinomaprospectivpilotresearch AT vbtskhai combinedhormonotherapywithgnrganalogueandintrauterinelevonorgestrelreleasingsystemofatypicalendometrialhyperplasiaandwelldifferentiatedendometrialcarcinomaprospectivpilotresearch AT ensivova combinedhormonotherapywithgnrganalogueandintrauterinelevonorgestrelreleasingsystemofatypicalendometrialhyperplasiaandwelldifferentiatedendometrialcarcinomaprospectivpilotresearch
_version_	1718417283762618368

COMBINED HORMONOTHERAPY WITH GNRG ANALOGUE AND INTRAUTERINE LEVONORGESTREL-RELEASING SYSTEM OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA: PROSPECTIV PILOT RESEARCH

Documents similaires